Free Access
| Issue |
Med Sci (Paris)
Volume 30, Number 8-9, Août–Septembre 2014
|
|
|---|---|---|
| Page(s) | 809 - 811 | |
| Section | Forum | |
| DOI | https://doi.org/10.1051/medsci/20143008021 | |
| Published online | 01 September 2014 | |
- Jordan B. Les retombées cliniques du séquençage de nouvelle génération. Med Sci (Paris) 2014 ; 30 : 589–594. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- André F, Bachelot T, Commo F, et al. Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER). Lancet Oncol 2014 ; 15 : 267–274. [CrossRef] [PubMed] [Google Scholar]
- Schwaederle M, Parker BA, Schwab RB, et al. Molecular tumor board: the University of California San Diego Moores cancer center experience. The Oncologist 2014 ; 5 mai (online). doi: 10.1634/theoncologist.2013–0405. [Google Scholar]
- Steel GG, Courtenay VD, Peckham MJ. The response to chemotherapy of a variety of human tumour xenografts. Br J Cancer 1983 ; 47 : 1–13. [CrossRef] [PubMed] [Google Scholar]
- Dong X, Guan J, English JC, et al. Patient-derived first generation xenografts of non-small cell lung cancers: promising tools for predicting drug responses for personalized chemotherapy. Clin Cancer Res 2010 ; 16 : bn1442–1445. [CrossRef] [Google Scholar]
- Kopetz S, Lemos R, Powis G. The promise of patient-derived xenografts: the best laid plans of mice and men. Clin Cancer Res 2012 ; 18 : 5160–5162. [CrossRef] [PubMed] [Google Scholar]
- Hidalgo M, Bruckheimer E, Rajeshkumar NV, et al. A pilot clinical study of treatment guided by personalized tumorgrafts in patients with advanced cancer. Mol Cancer Ther 2011 ; 10 : 1311–1316. [CrossRef] [PubMed] [Google Scholar]
- Garralda E, Paz K, López-Casas PP, et al. Integrated next-generation sequencing and avatar mouse models for personalized cancer treatment. Clin Cancer Res 2014 ; 20 : 2476–2484. [CrossRef] [PubMed] [Google Scholar]
- Karow J. Exome sequencing, avatar mouse models show promise for personalized cancer Rx. New trial started. GenomeWeb, Clinical Sequencing News, 7 mai 2014. [Google Scholar]
- Bruno A. Contribution au développement de nouvelles thérapies contre le cancer colorectal : l’initiative CReMEC. Med Sci (Paris) 2013 ; 29 : 239–242. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.